The acquisition, which is subject to regulatory approval, will be accretive to the Nestlé model both for growth and margins as well as the group’s earnings per share in the full first year.
Nestlé estimates the acquired business’ 2012 sales at $2.4bn.
85% of Pfizer Nutrition’s sales are in emerging markets, many of them with large, fast-growing populations. Pfizer Nutrition is an infant nutrition business that complements Nestlé’s existing portfolio with strong brands in key segments and geographies, according to the company.
Source: Nestlé
© FoodBev Media Ltd 2024